Global Mycoplasma Testing Market to Reach $1.9 Billion by 2030
The global market for Mycoplasma Testing estimated at US$966.3 Million in the year 2022, is projected to reach a revised size of US$1.9 Billion by 2030, growing at a CAGR of 8.6% over the analysis period 2022-2030. Assays, Kits & Reagents, one of the segments analyzed in the report, is projected to record 9.4% CAGR and reach US$940.8 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Services segment is readjusted to a revised 8.2% CAGR for the next 8-year period.The U.S. Market is Estimated at $255.6 Million, While China is Forecast to Grow at 12.8% CAGR
The Mycoplasma Testing market in the U.S. is estimated at US$255.6 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$483.2 Million by the year 2030 trailing a CAGR of 12.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.5% and 7.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR.Select Competitors (Total 11 Featured) -
- American Type Culture Collection (ATCC)
- Biological Industries Israel Beit Haemek Ltd.
- Biounique Testing Laboratories Inc.
- Charles River Laboratories International, Inc.
- Invivogen
- Lonza Group AG
- Merck KgaA
- Norgen Biotek Corporation
- Promocell GmbH
- Roche Diagnostics (Schweiz) AG
- SGS SA
- Thermo Fisher Scientific, Inc.
- Wuxi Apptec Co., Ltd.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- American Type Culture Collection (ATCC)
- Biological Industries Israel Beit Haemek Ltd.
- Biounique Testing Laboratories Inc.
- Charles River Laboratories International, Inc.
- Invivogen
- Lonza Group AG
- Merck KgaA
- Norgen Biotek Corporation
- Promocell GmbH
- Roche Diagnostics (Schweiz) AG
- SGS SA
- Thermo Fisher Scientific, Inc.
- Wuxi Apptec Co., Ltd.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 158 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 966.3 Million |
Forecasted Market Value ( USD | $ 1900 Million |
Compound Annual Growth Rate | 8.8% |
Regions Covered | Global |